These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35648358)

  • 21. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
    Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
    EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil and Macrophage Cell Surface Colony-Stimulating Factor 1 Shed by ADAM17 Drives Mouse Macrophage Proliferation in Acute and Chronic Inflammation.
    Tang J; Frey JM; Wilson CL; Moncada-Pazos A; Levet C; Freeman M; Rosenfeld ME; Stanley ER; Raines EW; Bornfeldt KE
    Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29891514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distance dependent shedding of IL-6R.
    Düsterhöft S; Bartels AK; Koudelka T; Lilienthal E; Schäfer M; Garbers C; Tholey A; Grötzinger J; Lorenzen I
    Biochem Biophys Res Commun; 2020 May; 526(2):355-360. PubMed ID: 32222277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis.
    Mishra HK; Ma J; Walcheck B
    Front Cell Infect Microbiol; 2017; 7():138. PubMed ID: 28487846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
    Schumacher N; Rose-John S
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119141. PubMed ID: 34610348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.
    Schumacher N; Schmidt S; Schwarz J; Dohr D; Lokau J; Scheller J; Garbers C; Chalaris A; Rose-John S; Rabe B
    J Immunol; 2016 Nov; 197(9):3705-3715. PubMed ID: 27698010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1.
    Fan D; Takawale A; Shen M; Samokhvalov V; Basu R; Patel V; Wang X; Fernandez-Patron C; Seubert JM; Oudit GY; Kassiri Z
    Hypertension; 2016 Oct; 68(4):937-48. PubMed ID: 27550917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
    Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
    Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.
    Almishri W; Swain LA; D'Mello C; Le TS; Urbanski SJ; Nguyen HH
    Front Immunol; 2021; 12():779119. PubMed ID: 35095853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAM17 cleaves the insulin receptor ectodomain on endothelial cells and causes vascular insulin resistance.
    Ghiarone T; Castorena-Gonzalez JA; Foote CA; Ramirez-Perez FI; Ferreira-Santos L; Cabral-Amador FJ; de la Torre R; Ganga RR; Wheeler AA; Manrique-Acevedo C; Padilla J; Martinez-Lemus LA
    Am J Physiol Heart Circ Physiol; 2022 Oct; 323(4):H688-H701. PubMed ID: 36018759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Status update on iRhom and ADAM17: It's still complicated.
    Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase-induced externalization of phosphatidylserine activates ADAM17 and impairs insulin signaling in endothelial cells.
    Ferreira-Santos L; Ramirez-Perez FI; Foote CA; Augenreich MA; McMillan NJ; Williams MB; Gonzalez-Vallejo JD; Power G; Wheeler AA; Manrique-Acevedo C; Martinez-Lemus LA; Padilla J
    Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H270-H277. PubMed ID: 37999645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes.
    Groth E; Pruessmeyer J; Babendreyer A; Schumacher J; Pasqualon T; Dreymueller D; Higashiyama S; Lorenzen I; Grötzinger J; Cataldo D; Ludwig A
    Biochim Biophys Acta; 2016 Nov; 1863(11):2795-2808. PubMed ID: 27599715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.
    Oldefest M; Düsterhöft S; Desel C; Thysen S; Fink C; Rabe B; Lories R; Grötzinger J; Lorenzen I
    Biochem J; 2015 Jun; 468(3):507-18. PubMed ID: 25846075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development.
    Toonen JA; Ronchetti A; Sidjanin DJ
    PLoS One; 2016; 11(5):e0156184. PubMed ID: 27224017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of
    Hu M; Hiroyasu S; Granville DJ; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H528-H534. PubMed ID: 35930445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial ADAM17 Expression in the Progression of Kidney Injury in an Obese Mouse Model of Pre-Diabetes.
    Palau V; Jarrín J; Villanueva S; Benito D; Márquez E; Rodríguez E; Soler MJ; Oliveras A; Gimeno J; Sans L; Crespo M; Pascual J; Barrios C; Riera M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.
    Swendeman S; Mendelson K; Weskamp G; Horiuchi K; Deutsch U; Scherle P; Hooper A; Rafii S; Blobel CP
    Circ Res; 2008 Oct; 103(9):916-8. PubMed ID: 18818406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of ADAM17 in metabolic inflammation.
    Menghini R; Fiorentino L; Casagrande V; Lauro R; Federici M
    Atherosclerosis; 2013 May; 228(1):12-7. PubMed ID: 23384719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?
    Ma X; Ma C; Zheng X
    Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.